282 related articles for article (PubMed ID: 9364473)
1. HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptors.
Schachter JB; Sromek SM; Nicholas RA; Harden TK
Neuropharmacology; 1997 Sep; 36(9):1181-7. PubMed ID: 9364473
[TBL] [Abstract][Full Text] [Related]
2. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
Horiuchi T; Dietrich HH; Hongo K; Dacey RG
Stroke; 2003 Jun; 34(6):1473-8. PubMed ID: 12730558
[TBL] [Abstract][Full Text] [Related]
3. Pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) as a tool for differentiation of P2Y2-receptor-mediated vasorelaxation in guinea pig aorta.
Payne SJ; Brown CA; Benjamin IS; Alexander B
Methods Find Exp Clin Pharmacol; 2002; 24(6):351-6. PubMed ID: 12224441
[TBL] [Abstract][Full Text] [Related]
4. Two subtypes of G protein-coupled nucleotide receptors, P2Y(1) and P2Y(2) are involved in calcium signalling in glioma C6 cells.
Sabala P; Czajkowski R; Przybyłek K; Kalita K; Kaczmarek L; Barańska J
Br J Pharmacol; 2001 Jan; 132(2):393-402. PubMed ID: 11159687
[TBL] [Abstract][Full Text] [Related]
5. Human Ntera-2/D1 neuronal progenitor cells endogenously express a functional P2Y1 receptor.
Moore DJ; Chambers JK; Murdock PR; Emson PC
Neuropharmacology; 2002 Nov; 43(6):966-78. PubMed ID: 12423666
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of the response to purinergic agonists in P2Y1 transfected 1321N1 cells by antagonists suramin and PPADS.
Brown CA; Charlton SJ; Boarder MR
Br J Pharmacol; 1997 Mar; 120(6):1049-52. PubMed ID: 9134216
[TBL] [Abstract][Full Text] [Related]
7. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
[TBL] [Abstract][Full Text] [Related]
8. Regulation of brain capillary endothelial cells by P2Y receptors coupled to Ca2+, phospholipase C and mitogen-activated protein kinase.
Albert JL; Boyle JP; Roberts JA; Challiss RA; Gubby SE; Boarder MR
Br J Pharmacol; 1997 Nov; 122(5):935-41. PubMed ID: 9384512
[TBL] [Abstract][Full Text] [Related]
9. Characterization of P2X3, P2Y1 and P2Y4 receptors in cultured HEK293-hP2X3 cells and their inhibition by ethanol and trichloroethanol.
Fischer W; Wirkner K; Weber M; Eberts C; Köles L; Reinhardt R; Franke H; Allgaier C; Gillen C; Illes P
J Neurochem; 2003 May; 85(3):779-90. PubMed ID: 12694404
[TBL] [Abstract][Full Text] [Related]
10. Ca(2+) signalling by recombinant human CXCR2 chemokine receptors is potentiated by P2Y nucleotide receptors in HEK cells.
Werry TD; Christie MI; Dainty IA; Wilkinson GF; Willars GB
Br J Pharmacol; 2002 Mar; 135(5):1199-208. PubMed ID: 11877327
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the existence of P2Y1,2,4 receptor subtypes in HEK-293 cells: reactivation of P2Y1 receptors after repetitive agonist application.
Fischer W; Franke H; Gröger-Arndt H; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):466-72. PubMed ID: 16025270
[TBL] [Abstract][Full Text] [Related]
12. P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages.
Bowler JW; Bailey RJ; North RA; Surprenant A
Br J Pharmacol; 2003 Oct; 140(3):567-75. PubMed ID: 12970084
[TBL] [Abstract][Full Text] [Related]
13. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.
Chhatriwala M; Ravi RG; Patel RI; Boyer JL; Jacobson KA; Harden TK
J Pharmacol Exp Ther; 2004 Dec; 311(3):1038-43. PubMed ID: 15345752
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological and second messenger signalling selectivities of cloned P2Y receptors.
Nicholas RA; Lazarowski ER; Watt WC; Li Q; Boyer J; Harden TK
J Auton Pharmacol; 1996 Dec; 16(6):319-23. PubMed ID: 9131407
[TBL] [Abstract][Full Text] [Related]
15. Evidence that rat hepatocytes co-express functional P2Y1 and P2Y2 receptors.
Dixon CJ; Woods NM; Webb TE; Green AK
Br J Pharmacol; 2000 Feb; 129(4):764-70. PubMed ID: 10683201
[TBL] [Abstract][Full Text] [Related]
16. Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus.
Rodrigues RJ; Almeida T; Richardson PJ; Oliveira CR; Cunha RA
J Neurosci; 2005 Jul; 25(27):6286-95. PubMed ID: 16000618
[TBL] [Abstract][Full Text] [Related]
17. ATP modulates intracellular Ca2+ and firing rate through a P2Y1 purinoceptor in cane toad pacemaker cells.
Ju YK; Huang W; Jiang L; Barden JA; Allen DG
J Physiol; 2003 Nov; 552(Pt 3):777-87. PubMed ID: 12949218
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of reactive blue 2 derivatives as selective antagonists for P2Y receptors.
Brown J; Brown CA
Vascul Pharmacol; 2002 Dec; 39(6):309-15. PubMed ID: 14567069
[TBL] [Abstract][Full Text] [Related]
19. Phosphate-substituted ATP analogs are antagonists at human P2Y1 purinoceptors.
Sak K; Raidaru G; Webb TE; Järv J
Arch Biochem Biophys; 2000 Sep; 381(1):171-2. PubMed ID: 11019833
[No Abstract] [Full Text] [Related]
20. Agonist action of adenosine triphosphates at the human P2Y1 receptor.
Palmer RK; Boyer JL; Schachter JB; Nicholas RA; Harden TK
Mol Pharmacol; 1998 Dec; 54(6):1118-23. PubMed ID: 9855642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]